Insight Molecular Diagnostics (IMDX) Goodwill (2020 - 2023)

Insight Molecular Diagnostics has reported Goodwill for 4 years, with the latest figure at $9.5 million in Q3 2023.

• Quarterly Goodwill fell 49.15% year-over-year to $9.5 million in Q3 2023, while the trailing twelve-month figure through Sep 2023 was $9.5 million (down 49.15% YoY) and the FY2022 annual result came in at $9.5 million, down 49.15% from the prior year.
• Goodwill steadied at $9.5 million in Q3 2023 per IMDX's latest filing, from $9.5 million in the prior quarter.
• Over five years, Goodwill peaked at $24.2 million in Q2 2021 and troughed at $9.2 million in Q1 2020.
• A 4-year average of $13.4 million and a median of $9.5 million in 2022 frame the typical range for Goodwill.
• The sharpest annual moves came in 2021 and 2022: Goodwill surged 163.82% in 2021, then sank 49.15% in 2022.
• Over 4 years, Goodwill stood at $9.2 million in 2020, then surged by 103.37% to $18.7 million in 2021, then sank by 49.15% to $9.5 million in 2022, then changed by 0.0% to $9.5 million in 2023.
• According to Business Quant data, Goodwill over the past three periods registered $9.5 million, $9.5 million, and $9.5 million for Q3 2023, Q2 2023, and Q1 2023 respectively.